Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lewis

Showing results (1211-1220 of 1,275) with videos related to

Pageof 128
Sort By:
Science (New York, N.Y.)|April 14, 2022
Getting genetic ancestry right for science and societyAnna C F Lewis, Santiago J Molina, Paul S Appelbaum, et al.
American Journal of Human Genetics|November 3, 2023
The GenoVA study: Equitable implementation of a pragmatic randomized trial of polygenic-risk scoring in primary careJason L Vassy, Charles A Brunette, Matthew S Lebo, et al.
Perspectives in Biology and Medicine|September 27, 2023
An Ethical Framework for Research Using Genetic AncestryAnna C F Lewis, Santiago J Molina, Paul S Appelbaum, et al.
Circulation|November 20, 2014
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trialMarc A Pfeffer, Brian Claggett, Susan F Assmann, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 21, 2025
Sacubitril/valsartan and Quality of Life Assessed Using the EuroQol 5-Dimension 3-Level Questionnaire Level Sum Score (EQ-5D-3L-LSS) in Patients with HFrEF and HFmrEF/HFpEFMingming Yang, Alasdair D Henderson, Inder S Anand, et al.
JACC. Heart Failure|June 10, 2025
Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary TrialsMats C H Lassen, John W Ostrominski, Brian L Claggett, et al.
The Canadian Journal of Cardiology|October 9, 2009
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendationsJacques Genest, Ruth McPherson, Jiri Frohlich, et al.
Nature Medicine|April 19, 2022
Development of a clinical polygenic risk score assay and reporting workflowLimin Hao, Peter Kraft, Gabriel F Berriz, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 28, 2007
Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trialJ M O'Brien, C D Adair, D F Lewis, et al.
American Heart Journal|November 1, 2020
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristicsGlenn M Chertow, Pablo E Pergola, Rajiv Agarwal, et al.
Pageof 128

Showing results (1211-1220 of 1,275) with videos related to

Sort By:
Pageof 128
Science (New York, N.Y.)|April 14, 2022
Getting genetic ancestry right for science and societyAnna C F Lewis, Santiago J Molina, Paul S Appelbaum, et al.
American Journal of Human Genetics|November 3, 2023
The GenoVA study: Equitable implementation of a pragmatic randomized trial of polygenic-risk scoring in primary careJason L Vassy, Charles A Brunette, Matthew S Lebo, et al.
Perspectives in Biology and Medicine|September 27, 2023
An Ethical Framework for Research Using Genetic AncestryAnna C F Lewis, Santiago J Molina, Paul S Appelbaum, et al.
Circulation|November 20, 2014
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trialMarc A Pfeffer, Brian Claggett, Susan F Assmann, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 21, 2025
Sacubitril/valsartan and Quality of Life Assessed Using the EuroQol 5-Dimension 3-Level Questionnaire Level Sum Score (EQ-5D-3L-LSS) in Patients with HFrEF and HFmrEF/HFpEFMingming Yang, Alasdair D Henderson, Inder S Anand, et al.
JACC. Heart Failure|June 10, 2025
Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary TrialsMats C H Lassen, John W Ostrominski, Brian L Claggett, et al.
The Canadian Journal of Cardiology|October 9, 2009
2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendationsJacques Genest, Ruth McPherson, Jiri Frohlich, et al.
Nature Medicine|April 19, 2022
Development of a clinical polygenic risk score assay and reporting workflowLimin Hao, Peter Kraft, Gabriel F Berriz, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 28, 2007
Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trialJ M O'Brien, C D Adair, D F Lewis, et al.
American Heart Journal|November 1, 2020
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristicsGlenn M Chertow, Pablo E Pergola, Rajiv Agarwal, et al.
Pageof 128